Startups
Heartseed（ハートシード）株式会社はiPS細胞による心臓の再生医療を実現します。慶應義塾大学医学部循環器内科福田恵一教授の技術を用いて心不全の治療を目指す革新的な大学発ベンチャーです。
Overview
Location
Japan, Tokyo
Total raised
$77.33M
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Angel Bridge | angelbridge.jp |
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jun 11, 2021 | Series C round | $37M | |
| Nov 22, 2019 | Series B round | $26M |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 2, 2023 | Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Regenerative Medicine | PALO ALTO, Calif., Nov. 2, 2023 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://www.ipeace.com), specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies based in Palo Alto, CA, and Heartseed Inc. ... |
| May 25, 2023 | Heartseed Raises 2 Billion JPY in Series D Funding | Heartseed, a Tokyo, Japan-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), raised 2 Billion JPY in Series D funding. The round, which brought the total amount to 10.2 Billion JPY (approx. $74M), saw... |
| Mar 29, 2022 | Heartseed Inc. Heartseed decides to adopt “Innovation TOKYO Project that opens up the future” | Heartseed Inc. Heartseed decides to adopt “Innovation TOKYO Project that opens up the future” It was adopted as a subsidy project of up to 300 million yen implemented by the Tokyo Metropolitan Government. Heartseed develops iPS cell-derived... |
| Jun 11, 2021 | Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure | Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it has raised 4 Billion-yen (approx. $37 Million) at Series C round, bringing its total financial backing to 8.2 B... |
| Jun 11, 2021 | Heartseed Raises $37M in Series C Funding | Heartseed, a Tokyo, Japan-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), raised 4 Billion-yen (approx. $37M) in Series C funding. The round brought its total financial backing to 8.2 Billion yen (... |
| Nov 26, 2019 | Daily funding roundup - November 25th, 2019 | Osome landed $3M; Rad AI raised $4M; Heartseed secured $26M; v2food picks up $35M Osome: Osome is a Fintech-as-a-service for entrepreneurs platform. Osome has raised $3 million financing led by Target Global, with participation from Phystec... |
| Nov 22, 2019 | Top tech startup news for today, Friday, November 22, 2019 – Tesla, AirBnB, Capitolis, Google, Next Coast Ventures | Good morning! Below are some of the top tech startup news for today, Friday, November 22, 2019. Tesla claimed its pickup truck was ‘bulletproof’ — then smashed its windows with a metal ball. You are probably tired of hearing about Tesla’s ... |
| Nov 22, 2019 | Heartseed Secures $26M in Series B Funding | Heartseed, a Tokyo, Japan-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), raised 2.8 Billion-yen (approx. $26m) in Series B funding. Backers in this round, which brought total fina... |
| Nov 22, 2019 | Tokyo tech startup Heartseed secures $26M Series B to accelerate development of iPSC-derived regenerative medicine for heart failure | Cardiovascular disease is the number one killer worldwide. Enter Heartseed, a developing PSC-derived cardiomyocytes for the treatment of heart failure. Heartseed is changing the world using regenerative medicine. Its breakthrough technology... |
Show more
Reviews 0
FAQ about Heartseed Inc.
How much funding has Heartseed Inc. raised?
Heartseed Inc. has raised $77.33M in total across 3 funding rounds.
What funding rounds has Heartseed Inc. raised?
Parsers VC lists 3 funding rounds of Heartseed Inc., among them a Series C round of $37M on Jun 11, 2021 and a Series B round of $26M on Nov 22, 2019.
Who has invested in Heartseed Inc.?
Parsers VC lists 2 investors of Heartseed Inc., among them Angel Bridge.
What has the press written about Heartseed Inc.?
Parsers VC has collected 11 articles mentioning Heartseed Inc., among them “Using iPS Cells from I Peace, Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes, A Major Step Forward in Advancing Autologous Cardiac Reg...” (Nov 2, 2023) and “Heartseed Raises 2 Billion JPY in Series D Funding” (May 25, 2023).
Is Heartseed Inc. still active?
Yes, Heartseed Inc. is active; its latest activity on Parsers VC dates from Sep 14, 2026.